HHTM

Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat, and prevent hearing loss disorders, announced new positive medical data from its clinical programs, SENS-501 and SENS-401, during a symposium at the 36th World Congress of Audiology (WCA) in Paris, held at CNIT, La Défense, France. The company presented data from

CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that preclinical results with ReSonance (ANP1), the company’s auditory neuronal cell transplant for the treatment of hearing loss, were presented at the 59th Annual Inner Ear Biology Workshop by Ofer Wiser, Ph.D. Senior Scientist, Technological Innovation

At the 2024 Academy of Doctors of Audiology conference, a panel featuring Andrew Bellavia, Steve Taddei, and David Kemp provided insights into current innovations in hearing healthcare with a focus on the integration of artificial intelligence (AI) in diagnostics, devices, and care delivery. The wide-ranging discussion began by diving into how AI-driven tools such as automated audiograms, real-ear measurements, and

EDEN PRAIRIE, MINNESOTA — Starkey has announced that its Chief Technology Officer, Achin Bhowmik, Ph.D., has been appointed as an Industry Representative for the U.S. FDA Digital Health Advisory Committee. The Digital Health Advisory Committee provides expert guidance to the FDA on matters related to the development and regulation of digital health technologies. Dr. Bhowmik’s selection reflects Starkey’s ongoing commitment

Miracle-Ear has been a leading brand in hearing care for more than seven decades, with a mission to improve lives through innovative hearing technology and personalized care. As one of the largest and most well-established hearing aid providers in the U.S., Miracle-Ear offers a diverse range of devices designed to meet the needs of individuals with varying degrees of hearing

WHITE BEAR LAKE, MINNESOTA – Envoy Medical®, Inc. (NASDAQ: COCH) has been granted a new patent by the US Patent & Trademark Office for its fully implanted hearing devices. The company announced today that it received Patent No. 12,081,061, titled “Recharge System for Implantable Battery,” on September 3rd. This latest patent relates to a system for predicting and managing the

FRANKFURT, KENTUCKY – During the AuDacity 2024 Conference, the Academy of Doctors of Audiology (ADA) announced the launch of the Audiology 2050 Initiative, laying out a bold vision for audiology’s future. With patient well-being at its core, the Audiology 2050 roadmap aims to solidify the role of audiologists as primary care providers for auditory and vestibular conditions, advance professional standards,

OKLAHOMA CITY, OK — Cisplatin, a widely used chemotherapy drug, has been a crucial treatment for many cancer patients, but its effectiveness often comes with a significant downside: irreversible hearing loss. Particularly pronounced in children, this side effect can drastically reduce quality of life, affecting learning and development. However, researchers at the University of Oklahoma, led by Dr. Vibhuti Agrahari,

A new study published in JAMA Otolaryngology introduces a prognostic model aimed at predicting hearing recovery in patients with idiopathic sudden onset sensorineural hearing loss (iSSNHL). This condition, characterized by a rapid, unexplained hearing loss, poses challenges for both patients and healthcare providers. The model aims to provide more clarity in treatment decisions, especially considering the variability in recovery outcomes.

CHICAGO, ILLINIOS – Beltone announced it has been recognized by USA TODAY as a Top Retailer in Hearing Care for 2024. To mark this achievement, the company is launching its Hear2End Hunger Food Drive, aimed at supporting communities nationwide through its network of locations. The Hear2End Hunger initiative addresses food insecurity, impacting 12.8% of U.S. households, including older adults. Beltone